APA (7th ed.) Citation

Chan, A. (2016). Neratinib in HER-2-positive breast cancer: Results to date and clinical usefulness.

Chicago Style (17th ed.) Citation

Chan, Arlene. Neratinib in HER-2-positive Breast Cancer: Results to Date and Clinical Usefulness. 2016.

MLA (9th ed.) Citation

Chan, Arlene. Neratinib in HER-2-positive Breast Cancer: Results to Date and Clinical Usefulness. 2016.

Warning: These citations may not always be 100% accurate.